Neonatal Infectious Diseases/Immunology

Neonatal Infectious Diseases/Immunology 1: Neonatal Infection - Risk Assessment

Neonatal Infectious Diseases/Immunology 2: Basic and Translational Science in Neonatal Infections

Neonatal Infectious Diseases/Immunology 3: Congenital Infections

Neonatal Infectious Diseases/Immunology 4: Neonatal immunology

Neonatal Infectious Diseases/Immunology Trainee Ongoing Projects

TOP 49 - Epidemiology and Microbiology of Admission Surveillance Nasal Swabs in a Level IV Neonatal Intensive Care Unit(NICU) and Their Association with Subsequent Infections

TOP 50 - Early Detection of Neonatal Sepsis Using Complete Blood Count Indices and Scores

TOP 51 - Correlation of cytokine profile of QuantiFERON®-CMV supernatants in neonates with congenital Cytomegalovirus Infection with long-term outcome: a pilot study

TOP 52 - Antibiotic Stewardship in Extremely Low Gestational Age Newborns (ELGAN): an Interdisciplinary Quality Improvement Project

TOP 53 - Treatment Outcomes of Invasive Infections due to Staphylococcus aureus in the Neonatal Intensive Care Unit (NICU): Can Antibiotic Duration be Shortened?

TOP 54 - Differentiating Ventilator Associated Pulmonary Infection from Tracheal Bacterial Colonization in VLBW Newborns

TOP 55 - From Placenta to Crib: Predictive Value of Placental Pathology in Neonatal Sepsis

430 - Plasma Microbial Cell-Free DNA in Well-Appearing Preterm Neonates

445 - Effect of early-life circadian rhythm disruption on myeloid cell reprogramming and immune response in neonatal mouse pups

475 - Patterns of syphilis diagnosis and treatment among maternal-infant dyads in a national sample, 2018-2024

490 - Comparative Efficacy of RSV Prophylaxis in High-Risk Infants

439 - Just-in-time Risk Stratification to Expedite Sepsis Evaluation and Treatment

454 - Modulating Acute and Chronic Systemic Pro-Inflammatory Cytokine and Chemokine Responses in Neonatal Sepsis

484 - Small but Not the Same: Small for Gestational Age (SGA) vs. Intrauterine Growth Restriction (IUGR) in Congenital Cytomegalovirus (cCMV) Infection

499 - Effect of Delayed Cord Clamping on T-Cell Homeostasis in Premature Neonates

440 - Descriptive study of bloodstream microorganisms in neonatal sepsis, and time to positivity in a level IV NICU

455 - Role of Oxysterols in NFκB-Mediated Systemic Inflammatory Responses in a Neonatal Mouse Model of Intestinal Perforation

485 - Cytomegalovirus (CMV) Infection in Very-Low-Birth-Weight (VLBW) Infants: Unraveling the Difference Between Congenital and Postnatal Infections

500 - Resolving factors that confound observed racial differences in vaginal microbiome trends during pregnancy

441 - Improved Detection of Neonatal Early-Onset Sepsis Pathogens Using Fetal Umbilical Venous Blood (FUVB) Cultures

456 - Arrested alveolar organogenesis in a newborn mouse inflammation model: protection by the interleukin (IL)-1 receptor antagonist rytvela

486 - Preliminary Results of a Phase II Open-Label Study of Maternal Donor-Derived Cytomegalovirus Cytotoxic T-Lymphocytes and Valganciclovir in Neonates with Moderate/Severe Maternal Acquired CMV Infection

501 - Challenges in newborn screening for primary immunodeficiency among preterm infants: Clinical features of patients with low TREC/KREC values

442 - Are we stuck in old ways? Reexamining empiric antibiotics guidelines in NICU

457 - Modulation of Interleukin (IL) -1 and -6 receptors prevents mouse preterm birth and newborn death due to a viral mimic.

487 - Congenital Cytomegalovirus Screening: Targeted vs. Expanded

502 - Infants exposed to a short course of antibiotics for a sepsis evaluation have increased Effector T cell proportions in their peripheral blood.

443 - Impact of Antepartum Antibiotics Characteristics and Placental Pathology on Time to Positivity of Blood Culture in Neonatal Early Onset Sepsis

458 - Mitigating the fetal inflammatory response syndrome (FIRS): modulating fetal membrane interleukin (IL)-1 and 6 receptors protect the fetus from bacterial and viral inflammatory stimuli

488 - Cytokine profile in QuantiFERON®-CMV supernatants in neonates with congenital Cytomegalovirus Infection

503 - Complete Blood Cell Count as a Predictor for Urinary Tract Infections in Hospitalized Neonates: A Case-Control Study

444 - Hypothermia and Early-Onset Neonatal Sepsis in Term Infants

459 - Prognostic Value of HMGB1 Levels for Mortality in Neonates with Suspected Sepsis

489 - Universal vs. Targeted CMV Testing in the NICU

504 - Redefining risk: The impact of early onset sepsis definitions on incidence and 14-Day mortality in preterm infants — a population-based study in Canada, 2010–2023

431 - National Trends in Escherichia coli Antibiotic Susceptibility in Neonatal Early-Onset Sepsis, 2009–2023

446 - CovR Regulation of GBS Virulence in the Newborn Gut

476 - Congenital Syphilis Cases in the Military Health System: A five-year review.

491 - Real-World Effectiveness of Nirsevimab against RSV-Related and All-Cause Respiratory Tract Infections in Chinese Infants: A Multicenter Cohort Study

432 - Epidemiology of multiple infections in NICU infants

447 - Proteomic Analysis of Mechanisms Underlying the Preconditioning Effect: Toward Improving Outcomes in Preterm Infants Exposed to Intrauterine Inflammation

477 - Serologic Screening for Syphilis at Delivery: Mother or Infant?

492 - Evaluation of Inflammatory Cytokine Expression in Pregnant Individuals with Opioid Use Disorder

433 - Antibiotic Stewardship in VLBW Newborns

448 - Investigating Group B Streptococcus Serotype-Specific Responses to Intestinal Physiological Stress

478 - Demographic Characteristics and Temporal Trends in Prevalence of Congenital Syphilis in Neonates in the United States from 2000 to 2022

493 - Impact of Gestational Maternal SARS-Cov-2 Infection on Neonatal Inflammatory Biomarkers.

434 - Barriers and Facilitators for Vancomycin Reduction in Preterm Infants: A Survey of Neonatal Clinicians

449 - Therapeutic Potential of Human Preterm Umbilical Cord-Derived Mesenchymal Stem Cells Exposed to Influenza A and COVID-19 in Murine Bronchopulmonary Dysplasia

494 - Severity of Fetal Inflammatory Response in Placenta is Associated with Early Onset Sepsis in Extremely Preterm Infants

435 - Risk factors for antibiotic resistant bacterial colonisation in European Neonatal Units – results of the NeoIPC feasibility study

450 - Maternal Lactoferrin Reduces Vertically-Acquired Escherichia coli Infection in the Offspring without Modifying Innate Immune Response in a Mouse Model

480 - Discharge Outcomes of Postnatal Cytomegalovirus Infection in Very Preterm Infants and Very Low Birth Weight Infants: A Multicenter Cohort Study

495 - Gestational and Postnatal Age-Dependent Dynamics of Serum Thymus and Activation-Regulated Chemokine(TARC) Levels in a Large Single-Center Cohort of Neonates

436 - Maternal Fever and PPROM Are Associated with Early Neonatal Illness Severity: A Composite Score Analysis in NICU Admissions

451 - Baseline Cardiopulmonary Function is Preserved in Young Adult Mice that Survive Neonatal Escherichia Coli Sepsis

481 - Missed Opportunities for Congenital CMV Testing After Failed Newborn Hearing Screens

437 - Development and Validation of ‘Clinical Prediction Model’ for Early onset sepsis in Preterm Neonates ≤ 34 weeks of gestation.

452 - Sequential Exposure to Intrauterine Inflammation and Postnatal Hyperoxia Alters Gene Expression in Cord Blood Monocytes

482 - Association of congenital cytomegalovirus infection and hearing screening in U.S. Neonatal intensive care units.

497 - Effect Of Exposure To Intrauterine Blood Transfusions On T-cell Subsets In Fetuses And Neonates With Rh Iso-immunization- A Cohort Study

438 - Variations in antibiotic use for culture-negative sepsis in near preterm and term newborns: A nationwide population based cohort

453 - Gene Expression Signatures in Cord Blood Monocytes After Exposure to Postnatal Hyperoxia

498 - Fetal Inflammatory Response Syndrome (FIRS) stage in placental pathology is associated with antibiotic use but not culture positive early onset sepsis in newborn inafnts.